[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69426530D1 - Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz - Google Patents

Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz

Info

Publication number
DE69426530D1
DE69426530D1 DE69426530T DE69426530T DE69426530D1 DE 69426530 D1 DE69426530 D1 DE 69426530D1 DE 69426530 T DE69426530 T DE 69426530T DE 69426530 T DE69426530 T DE 69426530T DE 69426530 D1 DE69426530 D1 DE 69426530D1
Authority
DE
Germany
Prior art keywords
regeneration
pharmaceutical
tissue healing
promote tissue
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69426530T
Other languages
English (en)
Inventor
Maurizio Tonetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69426530D1 publication Critical patent/DE69426530D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/69—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69426530T 1993-10-04 1994-09-30 Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz Expired - Lifetime DE69426530D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13095893A 1993-10-04 1993-10-04
PCT/IB1994/000300 WO1995009607A1 (en) 1993-10-04 1994-09-30 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it

Publications (1)

Publication Number Publication Date
DE69426530D1 true DE69426530D1 (de) 2001-02-08

Family

ID=22447200

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426530T Expired - Lifetime DE69426530D1 (de) 1993-10-04 1994-09-30 Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz

Country Status (8)

Country Link
US (1) US5795592A (de)
EP (1) EP0722312B1 (de)
JP (1) JPH09507212A (de)
CN (1) CN1056973C (de)
AT (1) ATE198418T1 (de)
CA (1) CA2173111A1 (de)
DE (1) DE69426530D1 (de)
WO (1) WO1995009607A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU759076B2 (en) * 1998-04-30 2003-04-03 Closure Medical Corporation Use of an adhesive composition over a bioactive polymerization initiator or accelerator
US6455064B1 (en) 1998-04-30 2002-09-24 Closure Medical Corporation Method of applying an adhesive composition over a bioactive polymerization initiator or accelerator
US6579469B1 (en) 1999-10-29 2003-06-17 Closure Medical Corporation Cyanoacrylate solutions containing preservatives
US6402518B1 (en) * 1999-11-30 2002-06-11 Arthur Ashman Method and apparatus for performing ridge augmentation
US6692526B1 (en) * 2000-03-15 2004-02-17 Michael E. Snyder Ophthalmological surgery colorant and delivery system
AU2000270527A1 (en) * 2000-08-24 2002-03-04 Lytone Enterprise, Inc. Delayed release compositions and combinations
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
US20090036849A1 (en) * 2005-12-22 2009-02-05 Sca Hygiene Products Ab Absorbent Article
DE102006033168A1 (de) * 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
DE102006033167A1 (de) 2006-07-10 2008-01-24 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
WO2009023122A1 (en) * 2007-08-10 2009-02-19 Ariston Pharmaceuticals, Inc. Cobalamin regimens for the treatment of nitrogen oxide-mediated conditions
DE102008062373A1 (de) * 2007-12-21 2009-06-25 Essiger, Holger, Dr. Mittel, mit mindestens einem Wirkstoff, der eine Zahnfleischwachstumswirkung aufweist
US10570390B2 (en) 2011-08-19 2020-02-25 Rodney J. Y. Ho Compositions, devices, and methods for treating infections

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175326A (en) * 1977-10-26 1979-11-27 Forsyth Dental Infirmary For Children Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
JPS59196814A (ja) * 1983-04-21 1984-11-08 Nippon Kayaku Co Ltd シ−ト状ニフエジピン製剤
JPS59222406A (ja) * 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
US4764377A (en) * 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
FR2591892B1 (fr) * 1985-12-23 1988-09-16 Pf Medicament Association collagene/principe actifantiseptique et/ou anti-inflammatoire a titre de composition, son procede de preparation et son utilisation pour la fabrication d'une composition pharmaceutique
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
JPH01238543A (ja) * 1988-03-16 1989-09-22 Shiseido Co Ltd 口腔用組成物
ATE111360T1 (de) * 1988-05-02 1994-09-15 Project Hear Chirurgisches klebstoffmaterial.
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US5075115A (en) * 1990-04-02 1991-12-24 Fmc Corporation Process for polymerizing poly(lactic acid)
US5130121A (en) * 1990-04-17 1992-07-14 Isp Investments Inc. Skin care compositions containing discrete microdroplets of an oil in water stabilized by in situ polymerization of water-soluble vinyl monomer
US5059123A (en) * 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate

Also Published As

Publication number Publication date
ATE198418T1 (de) 2001-01-15
EP0722312B1 (de) 2001-01-03
CA2173111A1 (en) 1995-04-13
JPH09507212A (ja) 1997-07-22
US5795592A (en) 1998-08-18
CN1056973C (zh) 2000-10-04
WO1995009607A1 (en) 1995-04-13
EP0722312A1 (de) 1996-07-24
CN1134107A (zh) 1996-10-23

Similar Documents

Publication Publication Date Title
HK1035336A1 (en) Use of preparations for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE69932183D1 (de) ANWENDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBS
DK0862416T3 (da) Ikke-polymert indgivelsessystem med forhalet frigørelse
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
WO2001041753A3 (en) Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
DE60112777D1 (de) Beschichtete medizinische geräte und verfahren zur sterilisation
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ATE259234T1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
BRPI0407178A (pt) Composição farmacêutica osteogênica
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
GB2331926A (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
KR960003741A (ko) 조골세포 증식인자
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
UA43800A (uk) Спосіб лікування перфоративної виразки дванадцятипалої кишки
DE68901018D1 (de) Arzneimittel zur regulierung der hormonellen sekretionen und zur behandlung der weiblichen sterilitaet.
RU98114855A (ru) Использование 1-энантиомер центхромана для получения фармацевтической композиции для лечения и профилактики рака молочной железы
UA33571A (uk) Спосіб лікування травматичного перелому нижньої щелепи
LT2002105A (en) Novel use of siberian fir oil
UA30556A (uk) Спосіб модуляції гоєння ран

Legal Events

Date Code Title Description
8332 No legal effect for de